MongoDB's share price has been under pressure, but I believe it remains a high-quality company with potential for double-digit revenue growth and high margins at scale. The recent success of PostgreSQL has raised questions about MongoDB's competitive positioning, although I believe that this has been overblown. MongoDB's customer base continues to expand, and expansion and retention rates remai...
After dropping more than 50% over the past year, MongoDB has become a very compelling buy at ~4.5x next year's revenue. Investors have reacted harshly to the company's expectations for 12-14% revenue growth in FY26, implying a sharp deceleration from Q4's 20% growth pace. The company has a track record for beating its conservative guidance, outperforming the high end of its original FY25 guidan...
Shares of MongoDB (MDB 0.05%) took a dive last month as the maker of NoSQL database software gave disappointing guidance for 2025 and got caught up in the broad market sell-off on fears around waning consumer confidence and the trade war.
The Nasdaq-100 -- which tracks the largest 100 nonfinancial companies on the Nasdaq stock exchange -- had a tough run in March as it finished the month down 7.7%. That marked one of the index's worst monthly performances in about two years.
It's been a challenging year for the U.S. stock market. The S&P 500 (^GSPC 0.67%) has declined 8% from its high, and the technology-focused Nasdaq Composite (^IXIC 0.87%) has fallen 14%.
MongoDB NASDAQ: MDB recently had a historically bad trading day after the database firm's latest earnings on Mar. 5, shares traded down by nearly 27%. As of the March 20 close, the stock is down over 47% from where it started 52 weeks ago.
The stock market has recovered from its correction territory, but there's still significant fear due to tariff-related uncertainty.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.